Talk:Multiple myeloma: Difference between revisions
Appearance
Content deleted Content added
→Etymology: new section |
|||
(26 intermediate revisions by 13 users not shown) | |||
Line 1: | Line 1: | ||
{{talkheader}} |
{{talkheader}} |
||
{{WikiProject banner shell|class=B| |
|||
⚫ | |||
⚫ | |||
}} |
|||
{{Reliable sources for medical articles}} |
{{Reliable sources for medical articles}} |
||
⚫ | |||
⚫ | |||
⚫ | |||
{{archives|bot=lowercase sigmabot III|age=1|units=year}} |
{{archives|bot=lowercase sigmabot III|age=1|units=year}} |
||
{{User:MiszaBot/config |
{{User:MiszaBot/config |
||
Line 13: | Line 16: | ||
| minthreadstoarchive=1 |
| minthreadstoarchive=1 |
||
}} |
}} |
||
⚫ | |||
== Reviews == |
|||
Numerous translational reviews in ''Blood'' this week: http://bloodjournal.org/content/125/20 - 15 May 2015 |
|||
==Relapse== |
|||
Proposed edit: Following the sentence "Bortezomib is a proteasome inhibitor," add, "Identifying the levels of specific proteins may help doctors identify whether a patient will benefit from a proteasome inhibitor." Citation: [[doi:10.18632/oncoscience.356]] |
|||
I'd like to open this to discussion because the citation is primary research, so not ideal. However, the first sentence does not give readers any context as the significance of being a proteasome inhibitor or how physicians use that information. The purpose of this edit would be to help fill that gap. Thoughts? [[User:Cglife.trummler|Cglife.trummler]] ([[User talk:Cglife.trummler|talk]]) 22:43, 14 November 2017 (UTC) |
|||
:I'm sure there are better sources that are more compliant with [[WP:MEDRS]]. I find a fair number when searching Pubmed with "proteasome inhibitors" as MAJR term. [[User:Jfdwolff|JFW]] | [[User_talk:Jfdwolff|<small>T@lk</small>]] 23:01, 14 November 2017 (UTC) |
|||
:No. We call this [[WP:REFSPAM]]. Please stop doing this. Thanks. [[User:Jytdog|Jytdog]] ([[User talk:Jytdog|talk]]) 06:13, 15 November 2017 (UTC) |
|||
== Updating and expanding prognosis info == |
|||
Two points: |
|||
1. The Prognosis section states "Overall the 5-year survival rate is around 35%". The source for this (63) states "Archived from the original on 11 January 2013." However, following the source link given leads to an article that notes at the top it has been updated on Jan 11, 2018. In that article, under the heading Prognosis it says "The 5-year relative survival rate is 46.6%." |
|||
I am not expert enough to know if "overall" and "relative" have different meanings in this context, but it appears to me as if the survival rate has improved since the original source was written. Should this be updated? |
|||
2. The same source (https://emedicine.medscape.com/article/204369-overview#showall) also gives information on the difference in prognosis due to type of treatment: |
|||
{{Quote frame|The prognosis by treatment is as follows: |
|||
• Conventional therapy: Overall survival is approximately 3 years, and event-free survival is less than 2 years. |
|||
• High-dose chemotherapy with stem-cell transplantation: The overall survival rate is greater than 50% at 5 years.}} |
|||
This might be good information to include. |
|||
[[User:Grindle2095|Grindle2095]] ([[User talk:Grindle2095|talk]]) 13:41, 27 January 2018 (UTC) |
|||
==Wiki Education assignment: Epidemiology ENPH 450== |
|||
:Medscape isn't an ideal source. I agree that there must be a more recent [[WP:MEDRS|MEDRS]]-compatible source present somewhere. [[User:Jfdwolff|JFW]] | [[User_talk:Jfdwolff|<small>T@lk</small>]] 22:49, 27 January 2018 (UTC) |
|||
{{dashboard.wikiedu.org assignment | course = Wikipedia:Wiki_Ed/University_of_Wisconsin-Eau_Claire/Epidemiology_ENPH_450_(Fall) | assignments = [[User:Brownwahlee|Brownwahlee]] | start_date = 2022-09-05 | end_date = 2022-12-17 }} |
|||
<span class="wikied-assignment" style="font-size:85%;">— Assignment last updated by [[User:Schmidtj5997|Schmidtj5997]] ([[User talk:Schmidtj5997|talk]]) 00:58, 29 November 2022 (UTC)</span> |
|||
::How about SEER Cancer Statistics Review? (https://seer.cancer.gov/csr/1975_2014/) (Based on data up to 2014) You can see the relevant tables here: https://seer.cancer.gov/csr/1975_2014/browse_csr.php?sectionSEL=18&pageSEL=sect_18_table.08.html [[User:Grindle2095|Grindle2095]] ([[User talk:Grindle2095|talk]]) 06:58, 28 January 2018 (UTC) |
|||
== Etymology == |
|||
==Alcohol as a risk factor?== |
|||
The WHO report used as a ref in our article says |
|||
:''"Associations have been reported between alcohol consumption and cancer of the cervix, endometrium, ovary, vulva and vagina, testis, brain, thyroid, and skin (malignant melanoma, basal cell carcinoma, and squamous cell carcinoma) as well as leukaemia and multiple myeloma [5]; however, few studies have examined these associations"'' |
|||
...which is very waffly, and seems to use as its reference: https://www.ncbi.nlm.nih.gov/books/NBK326568/?report=printable - which actually says: |
|||
:''"Two cohort studies, one in a group of radiological technologists exposed to ion- izing radiation in the USA (Freedman et al., 2003) and one in alcoholic women in Sweden (Sigvardsson et al., 1996), found '''no significant associations''' between the risk for melanoma and alcoholic beverage intake."'' (my emphasis). |
|||
Also see https://www.ncbi.nlm.nih.gov/pubmed/24469244 which found an ''inverse'' relationship. - [[User:Snori|Snori]] ([[User talk:Snori|talk]]) 08:54, 6 August 2018 (UTC) |
|||
::Hum yes. Agree and will remove. [[User:Doc James|<span style="color:#0000f1">'''Doc James'''</span>]] ([[User talk:Doc James|talk]] · [[Special:Contributions/Doc James|contribs]] · [[Special:EmailUser/Doc James|email]]) 12:50, 6 August 2018 (UTC) |
|||
It might be good to cover the etymology. If Multiple Myeloma involves plasma cells, which are lymphoid, not myeloid, in origin, then why is it called myeloma? Diagnosis: What distinguishes myeloma from (non-hodgkins) lymphoma? [[User:Eaberry|Eaberry]] ([[User talk:Eaberry|talk]]) 18:26, 5 December 2024 (UTC) |
|||
==Revert of good faith edits== |
|||
User [[User:StevealexR1]] just changed some ages that have been there for some time and had associated refs/cites. Presumably these support those figures, so even if this user *thinks* they know better the fact and the ref now don't match. Also added some slightly odd treatment options - these may be fine ''if'' backed up with refs. - [[User:Snori|Snori]] ([[User talk:Snori|talk]]) 19:12, 20 December 2018 (UTC) |
Latest revision as of 18:26, 5 December 2024
This is the talk page for discussing improvements to the Multiple myeloma article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 12 months |
This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Multiple myeloma.
|
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
|
|
This page has archives. Sections older than 365 days may be automatically archived by Lowercase sigmabot III when more than 4 sections are present. |
Wiki Education assignment: Epidemiology ENPH 450
[edit]This article was the subject of a Wiki Education Foundation-supported course assignment, between 5 September 2022 and 17 December 2022. Further details are available on the course page. Student editor(s): Brownwahlee (article contribs).
— Assignment last updated by Schmidtj5997 (talk) 00:58, 29 November 2022 (UTC)
Etymology
[edit]It might be good to cover the etymology. If Multiple Myeloma involves plasma cells, which are lymphoid, not myeloid, in origin, then why is it called myeloma? Diagnosis: What distinguishes myeloma from (non-hodgkins) lymphoma? Eaberry (talk) 18:26, 5 December 2024 (UTC)
Categories:
- B-Class medicine articles
- Mid-importance medicine articles
- B-Class hematology-oncology articles
- Unknown-importance hematology-oncology articles
- Hematology-oncology task force articles
- All WikiProject Medicine pages
- Start-Class articles with conflicting quality ratings
- Start-Class Veterinary medicine articles
- Mid-importance Veterinary medicine articles
- WikiProject Veterinary medicine articles
- Talk pages of subject pages with paid contributions